Plasmapheresis is a very effective modality of treatment for many of the immune-mediated neurological disorders. It is a relatively new concept in the context of our country. Although it was previously done in one or two of the private hospitals but the expense was beyond the affordability of m59ost of our patients. Since its inception on September, 2012 the National Institute of Neurosciences & Hospital (NINS) has made some major advancement in patient management. Initiation of plasmapheresis at an affordable cost is one such example. In this article we intend to share our experience of the few cases who have received this treatment. [Journal of National Institute of Neurosciences Bangladesh, 2015;1(2): [62][63][64] 
Introduction
Plasmapheresis (from the Greekπλάσμα-plasma, something molded, and φαίρεσις-aphairesis, taking away) is the removal, treatment, and return of (components of) blood plasma from blood circulation 1 . It is thus an extracorporeal therapy. The most common term is plasmapheresis, which technically means removal of plasma only, for the proper term, ''plasma exchange'', which technically refers to both removal of plasma and its replacement 2 . In the literature, these terms are used interchangeably.
History
Michael Rubinstein was the first person to use plasmapheresis to treat an immune-related disorder when he "saved the life of an adolescent boy with thrombotic thrombocytopenic purpura (TTP) at the old 
Mechanics
During plasmapheresis, blood is initially taken out of the body through a needle or previously implanted catheter 5 . Plasma is then removed from the blood by a cell separator. Three procedures are commonly used to separate the plasma from the blood cells, with each method having its own advantages and disadvantages 6 : • Discontinuous flow centrifugation: One venous catheter line is required. Typically, a 300 ml batch of blood is removed at a time and centrifuged to separate plasma from blood cells.
• Continuous flow centrifugation: Two venous lines are used. This method requires slightly less blood volume out of the body at any one time, as it is able to continuously spin out plasma.
• Plasma filtration: Two venous lines are used. The plasma is filtered using standard hemodialysis equipment. This continuous process requires that less than 100 ml of blood be outside the body at one time. After plasma separation, the blood cells are returned to the person undergoing treatment, while the plasma, which contains the antibodies, is first treated and then returned to the patient in traditional plasmapheresis. In plasma exchange, the removed plasma is discarded and the patient receives replacement donor plasma, albumin, or a combination of albumin and saline (usually 70% albumin and 30% saline). An anticoagulant usually citrate is given to the patient during the procedure. Plasmapheresis is used as a therapy in particular diseases. It is an uncommon treatment in the United States, but it is more common in Europe and particularly Japan.
Presumed Mechanisms
A variety of possible mechanisms for the actions of therapeutic PP has been proposed, including removal of antibody, alloantibody, immune complexes, monoclonal protein, toxin or cytokine(s), replenishment of a specific plasma factor, and, lastly, the placebo effect 7 . For most neurologic diseases, patient improvement is associated with a drop in antibody titers as a result of PP. It should be noted, however, that other mechanisms may exist. Indeed, PP can be looked upon as a ''blunderbuss'' that removes all the nonformed elements in plasma, including immunoglobulin, cytokines, and other serum factors, in a nonspecific fashion 8 . The specific factor whose removal is crucial in therapeutically successful PP is thus not specifically known.
Complications of Plasmapheresis Therapy
Though plasmapheresis is helpful in certain medical conditions, like any other therapy, there are potential risks and complications. Insertion of a rather large intravenous catheter can lead to bleeding, pneumothorax, thrombosis (in case of CV line), and thrombophlebitis 3 . Aside from placing the catheter, the procedure itself has complications. Citrate is infused while the blood is running through the circuit. It is an effective anticoagulant that binds to calcium in the blood. This can lead to life-threateningly hypocalcaemia which can be detected using the Chvostek's sign or Trousseau's sign 5 . To prevent this complication, calcium is infused intravenously while the patient is undergoing the plasmapheresis; in addition, calcium supplementation by mouth may also be given. Other complications include 
Conclusion
Plasmapheresis is used for immune-mediated neurological disorders which is limited treatment modalities in Bangladesh. Application of this treatment facility at National Institute of Neurosciences & Hospital has given a new window in a low cost. This facility should be applied for the neurologic disorders patients of this country.
